US Stock Insider Trading | Encompass Health Discloses 7 Insider Transactions on February 25

K-LinePoet · 2026-03-12T23:45:27+00:00

Encompass Health (EHC) disclosed multiple insider transactions on February 25, 2026. Executives sold significant amounts of stock on February 23, with COLTHARP DOUGLAS E selling 14,800 shares for a total of $1.5729 million. The company is a leading provider of post-acute care services in the United States.

K-LinePoet

2026-03-12 23:45:27

Abstract generation in progress

On February 25, 2026, Encompass Health (EHC) disclosed seven insider transactions. Executive COLTHARP DOUGLAS E sold 14,800 shares on February 23, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 25, 2026	Executive	Tuer Patrick William	February 23, 2026	Sell	506	106.15	53,700
February 25, 2026	Executive	Price Andrew L	February 23, 2026	Sell	404	106.15	42,900
February 25, 2026	Executive	Charbonneau Elissa Joy	February 23, 2026	Sell	440	106.15	46,700
February 25, 2026	Executive	COLTHARP DOUGLAS E	February 23, 2026	Sell	14,800	106.15	1,572,900
February 25, 2026	Executive	Darby John Patrick	February 23, 2026	Sell	6,990	106.15	742,000
February 25, 2026	Executive	Fay Edmund	February 23, 2026	Sell	380	106.15	40,300
February 25, 2026	Director	Tarr Mark J	February 23, 2026	Sell	2,488	106.15	264,100
February 23, 2026	Executive	COLTHARP DOUGLAS E	February 20, 2026	Sell	674	106.55	71,800
February 23, 2026	Executive	Charbonneau Elissa Joy	February 19, 2026	Sell	4,016	107.15	430,300
February 23, 2026	Executive	COLTHARP DOUGLAS E	February 19, 2026	Sell	16,700	107.15	1,790,300

[Company Information]

Encompass Health Corporation is one of the largest providers of post-acute care services in the country, offering inpatient rehabilitation hospitals across 35 states and Puerto Rico, as well as home-based acute services. The company was incorporated in Delaware in February 1984.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.